The Brainy Stuff
MSCs are kind of our thing; we can’t get enough of them
For more publications, see the RoosterReference Database(.xls)
Grigoryan B, Paulsen SJ, Corbett DC, Sazer DW, Fortin CL, Zaita AJ, Greenfield PT, Calafat NJ, Gounley JP, Ta AH, Johansson F, Randles A, Rosenkrantz JE, Louis-Rosenberg JD, Galie PA, Stevens KR, Miller JS. Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Science. 2019 May
Hogan SE, Rodriguez Salazar MP, Cheadle J, Glenn R, Medrano C, Petersen TH, Ilagan RM. Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2019 May
Fairag R, Rosenzweig DH, Ramirez-Garcialuna JL, Weber MH, Haglund L. Three-Dimensional Printed Polylactic Acid Scaffolds Promote Bone-like Matrix Deposition in Vitro. ACS Appl Mater Interfaces. 2019 May
Castilla-Casadiego DA, Garcia JR, Garcia AJ, Almodovar J. Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma. ACS Biomater. Sci. Eng. 2019 May
Saiz AM Jr, Gionet-Gonzales MA, Lee MA, Leach JK. Conditioning of myoblast secretome using mesenchymal stem/stromal cell spheroids improves bone repair. Bone. 2019 Aug
From the lab of Adam Hsieh at University of Maryland: Vimentin Knockdown Impairs Neo-Cartilage Formation in Human Mesenchymal Stem Cell Pellet Cultures. Presented at ORS; San Diego, CA; March 2017.
From the lab of Jordan Miller at Rice University: Open-source Selective Laser Sintering (OpenSLS) of nylon and biocompatible polycaprolactone. World Biomaterials Congress; Montreal, Canada; May, 2016.
From the lab of Jordan Miller at Rice University: Engineered tissues with perfusable vascular networks created by sacrificial templating of laser sintered carbohydrates. World Biomaterials Congress; Montreal, Canada; May, 2016.
From the lab of Jordan Miller at Rice University: Tubulogenesis of iPS Endothelial Cells Stabilized by Human Mesenchymal Stem Cells in Fibrin Gels. World Biomaterials Congress; Montreal, Canada; May, 2016.
From the lab of Larry Bonassar at Cornell: Differential MHC Class Receptor Expression in In Vitro Human Mesenchymal Stem Cells is Mediated by Scaffold Material. Presented at ORS; Orlando, FL; March, 2016.
From the lab of Larry Bonassar at Cornell: Effect of Hypoxia on 2D and 3D Culture of Human MSCs Used for Tissue Engineering of Whole Intervertebral Discs. Presented at ORS; Orlando, FL; March, 2016.
From the lab of Larry Bonassar at Cornell: Co-Implantation of Auricular Chondrocytes and Mesenchymal Stem Cells for Auricular Cartilage Generation. Presented at TERMIS World Congress; Boston, MA; Dec, 2015.
From the lab of Eric Brey at Illinois Institute of Technology: Evaluation of MSC Source on Angiogenesis in 3D Co-Culture. Presented at TERMIS World Congress; Boston, MA; Dec, 2015.
From the lab of Larry Bonassar at Cornell: The Influence of TGF-β3 on the Maturation of Tissue Engineered IVDs Containing Highly Contractile Human MSCs. Presented at ORS; Las Vegas, NV; March, 2015.
From the lab of Lisa Larkin at U Michigan: Characterization of a Human MSC Population Required for Scaffold-less Construct Fabrication. Presented at ORS; Las Vegas, NV; March, 2015.
RoosterBio-BioBots collaboration: Welcome to the Golden Age of BioPrinting, Tissue Engineering and BioFabrication. Frederick, MD; Dec, 2014.
From PBS Biotech: Screening Study of Key Process Conditions for Anchorage-Dependent Stem Cell Cultivation in Scale-Down Model of Vertical-Wheel Bioreactors. Presented at Scale-Up and Manufacturing of Cell Therapies IV; San Diego, CA; Jan, 2015.
Economics and Quality Attributes of hMSC Production in Xeno-free Bioprocessing Media. Scale-up and Manufacturing of Cell-based Therapies V; San Diego, CA; January 15-19, 2017.
Cost and Quality Attributes of hMSC Production in Xeno-free Bioprocessing Media. BPI Cell & Gene Therapy Conference; Boston, MA; October 5-7, 2016.
Scalable Expansion OF hBM-MSC in a Fed-Batch Microcarrier Suspension Bioreactor. ISSCR; San Francisco, CA; June 22-25, 2016.
Scalable bioreactor-based production of human Mesenchymal Stem Cell (hMSC) 3D aggregates using microcarriers with thermo-reversible surfaces. ISSCR; San Francisco, CA; June 22-25, 2016.
Cryopreserved hMSCs maintain comparable in vitro functional activity compared to fresh hMSCs. Presented at ISCT; Las Vegas, NV; May 27-30, 2015.
Rapid and Economic Generation of consistent hMSC Spheroids for Macroscopic Tissue Biofabrication and Therapeutic Applications. Presented at ISCT; Las Vegas, NV; May, 2015.
A Standardized and Well-Characterized MSC Source for Rapid Biofabrication & Translational Research. Presented at TERMIS AM; Washington, DC; Dec, 2014.
Consistent Enhancement of Mesenchymal Stem Cells (MSC) Function and Properties by IFNγ and TNFα Treatment In Vitro. Presented at TERMIS AM; Washington, DC; Dec, 2014.
A Standardized and Well-Characterized MSC Source for Translational Researchers. Presented at the McGowan Institute Retreat; Nemacolin Woodlands, PA; March, 2014.
A Xeno-Free Fed-Batch Microcarrier Suspension Bioreactor System for the Scalable and Economic Expansion of hBM-MSCs. Presented at the ISCT meeting; Montreal, Canada; May, 2018.
To request a PDL and DT Calculator Excel Spreadsheet, please email us at email@example.com.